RSV vaccine (GSK3003891A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV vaccine (GSK3003891A), covering 2017-07-11 to 2017-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women [Phase 2]